MINAPHARM Pharmaceuticals (EGX:MIPH)
221.02
-12.34 (-5.29%)
At close: Jun 23, 2025
MINAPHARM Pharmaceuticals Revenue
In the year 2024, MINAPHARM Pharmaceuticals had annual revenue of 5.66B EGP with 45.55% growth. MINAPHARM Pharmaceuticals had revenue of 2.08B in the quarter ending December 31, 2024, with 147.41% growth.
Revenue
5.66B
Revenue Growth
+45.55%
P/S Ratio
0.46
Revenue / Employee
12.59M
Employees
450
Market Cap
2.60B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 5.66B | 1.77B | 45.55% |
Dec 31, 2023 | 3.89B | 271.51M | 7.50% |
Dec 31, 2022 | 3.62B | 615.19M | 20.47% |
Dec 31, 2021 | 3.01B | 644.34M | 27.29% |
Dec 31, 2020 | 2.36B | 309.95M | 15.11% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Commercial International Bank Egypt (CIB) S.A.E. | 107.76B |
El Sewedy Electric Company | 246.12B |
Talaat Moustafa Group Holding | 45.30B |
Eastern Company S.A.E | 34.08B |
Misr Fertilizer Production Company | 21.20B |
Alexandria Container&Cargo Handling Company | 8.41B |
Egypt Aluminum | 42.42B |
Telecom Egypt Company | 89.35B |